Table 2.
Nanomedicine-promoted strategies for mPTT synergized with chemotherapy.
Improved chemotherapy efficacy by Mptt | Nanomedicine | PTA | Chemotherapeutic agents | Mechanisms | Ref. |
---|---|---|---|---|---|
Cellular uptake |
|
ICG | PTX |
|
[25] |
|
AuNRs | Dox | [57] | ||
|
PDA | Chlorambucil | [58] | ||
|
CuS | Dox | [59] | ||
|
Polypyrrole (PPy) | Docetaxel (DTX) | [60] | ||
|
AuNRs | HPMA copolymers |
|
[20] | |
|
AuNRs | Gemcitabine |
|
[61] | |
|
Porous silicon (PSi) | Temozolomide (TMZ) |
|
[62] | |
|
IR780 | PTX |
|
[63] | |
Drug release |
|
Au | Dox |
|
[64] |
|
CuS | Dox | [59] | ||
|
Single-walled carbon | Dox | [65] | ||
|
PDA | aHLP | [66] | ||
|
Au | Dox | [67] | ||
|
PDA | SN38 | [68] | ||
|
PDA | Dox | [69] | ||
|
AuNRs | Dox |
|
[57] | |
|
Ag2S | Dox | [70] | ||
|
PDA | Chlorambucil | [58] | ||
|
Gold-nanodot-decorated hollow carbon | Dox | [71] | ||
|
Au | Dox |
|
[72] | |
|
AuNRs | STS | [73] | ||
|
Au | Dox | [74] | ||
|
AuNRs | Dox | [75] | ||
|
Nd3+-doped upconversion nanoparticle | Dox | [76] | ||
|
Cu | 5-FU, PTX | [77] | ||
|
Ag2S | Dox |
|
[70] | |
|
Melanin | Obatoclax (OBX) |
|
[78] | |
Drug resistance |
|
MoS2 | Dox |
|
[79] |
|
Gold-nanodot-decorated hollow carbon | Dox |
|
[71] | |
|
PDA | Dox | [69] | ||
|
Au | Dox | [80] | ||
|
Au | Dox |
|
[74] | |
|
Pt | Cisplatin |
|
[81] |